Literature DB >> 11299119

Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.

E H Hoffmann1, L A da Silveira, R Tonhosolo, F J Pereira, W L Ribeiro, A P Tonon, F Kawamoto, M U Ferreira.   

Abstract

The polymorphic merozoite surface protein-2 (MSP-2) of Plasmodium falciparum is a major malaria-vaccine candidate. In the present study, PCR and hybridization with allelic-specific probes were used to type the Msp-2 gene from isolates from hypo-endemic Brazil (N = 113), meso-endemic Vietnam (N = 208) and holo-endemic Tanzania (N = 67). The typing methods were designed to group isolates into the dimorphic allelic families FC27 and IC1 and to detect possible between-family recombination events. The analysis was complemented by a comparison of 156 Msp-2 sequences from the GenBank database with 12 additional sequences obtained during the present study. Statistically significant differences were detected in pair-wise comparisons of the distribution of Msp-2 allelic types in Brazil and Vietnam, and in Brazil and Tanzania, but not in Vietnam and Tanzania. The extent of allelic diversity in the Msp-2 gene, as estimated by the total number of different alleles found in a given parasite population and the mean multiplicity of infections, clearly paralleled the levels of malaria endemicity in the study areas. However, no correlation between age and multiplicity of infections was found in the subjects. The patterns of Msp-2 diversity in Brazil appeared to be temporally stable, since no significant difference was observed in the distribution of Msp-2 allelic types among isolates collected, 10--13 years apart, in the same area of Rondônia. Despite the extensive sequence diversity found in Msp-2 alleles, especially in the central repetitive region of the molecule, several instances of identical or nearly identical alleles were found among isolates from different countries and regions, possibly as a result of extensive homoplasy. No recombinant allele was detected by molecular typing in any of the study sites, and the GenBank database included only 12 recombinant sequences (representing 7% of all reported Msp-2 sequences), all of them with an IC1-type 5' end and an FC27-type 3' end. A single, putative, crossover site was characterised for all recombinant alleles. Most of the allelic diversity observed was therefore attributable to variation in the repetitive region of the gene, instead of recombination between alleles of dimorphic families (as commonly found, for example, in the Msp-1 gene). The implications of these findings for studies on the genetic and antigenic diversity of malarial parasites are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299119     DOI: 10.1080/00034980120045833

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  27 in total

1.  Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1.

Authors:  Alfred Cortés; Mata Mellombo; Ivo Mueller; Ariadna Benet; John C Reeder; Robin F Anders
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil.

Authors:  Kelly A Kanunfre; Fabiana M S Leoratti; Erika H E Hoffmann; Rui R Durlacher; Antônio W Ferreira; Sandra L Moraes-Avila; Marcelo U Ferreira
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

3.  Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies.

Authors:  Janine Stubbs; Sope Olugbile; Balam Saidou; Jacques Simpore; Giampietro Corradin; Antonio Lanzavecchia
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

Review 4.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar.

Authors:  Jung-Mi Kang; Sung-Ung Moon; Jung-Yeon Kim; Shin-Hyeong Cho; Khin Lin; Woon-Mok Sohn; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

6.  Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits.

Authors:  Kwadwo A Kusi; Bart W Faber; Marjolein van der Eijk; Alan W Thomas; Clemens H M Kocken; Edmond J Remarque
Journal:  Malar J       Date:  2011-02-14       Impact factor: 2.979

7.  Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.

Authors:  Ambroise D Ahouidi; Amy K Bei; Daniel E Neafsey; Ousmane Sarr; Sarah Volkman; Dan Milner; Janet Cox-Singh; Marcelo U Ferreira; Omar Ndir; Zul Premji; Souleymane Mboup; Manoj T Duraisingh
Journal:  Infect Genet Evol       Date:  2009-11-30       Impact factor: 3.342

8.  Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.

Authors:  Christopher G Adda; Christopher A MacRaild; Linda Reiling; Kaye Wycherley; Michelle J Boyle; Vivian Kienzle; Paul Masendycz; Michael Foley; James G Beeson; Raymond S Norton; Robin F Anders
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

9.  Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon.

Authors:  Agnès Aubouy; Florence Migot-Nabias; Philippe Deloron
Journal:  Malar J       Date:  2003-05-09       Impact factor: 2.979

10.  Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping.

Authors:  Sonja Schoepflin; Francesca Valsangiacomo; Enmoore Lin; Benson Kiniboro; Ivo Mueller; Ingrid Felger
Journal:  Malar J       Date:  2009-10-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.